OPERATOR-LED INTELLIGENCE

35 years of biopharma
operating experience,
encoded.

KatogenOS is the command center for an advisory practice built on doing, not theorizing. Every deal closed, every capital raise structured, every turnaround executed, distilled into one operating system.

View Deal Pipeline →
17 Acquisitions Closed Across three continents
$4B+ Capital Raised Debt, equity, licensing
35+ Years Operating CEO-level biopharma
35 Countries Global pharmaceutical reach

Six domains.
One operator.

Every engagement starts with the founder. No sales team. No junior handoff. The person who closed the deals is the person in the room.

01

M&A Advisory

Full deal lifecycle from target identification through post-merger integration. 17 completed acquisitions. We know where deals break down and how to prevent it.

02

Capital Strategy

Structuring and executing capital raises across debt, equity, licensing, and partnerships. $4B+ raised through disciplined capital architecture.

03

Product Commercialisation

Launch strategy, payer negotiations, formulary access, and pricing decisions. From molecule to market with operator precision.

04

Board Advisory

Independent board-level perspective on strategic decisions and governance. Having chaired NASDAQ-listed boards, we bring experience, not theory.

05

Fractional C-Suite

Interim CEO and executive leadership for companies at critical inflection points. Step in, stabilize, scale, step back.

06

Strategic Consulting

General strategic guidance from early-stage biotech to mature pharmaceutical operations. Every decision informed by three decades of doing it for real.

Operator expertise,
on demand.

Three proprietary tools that encode decades of biopharma operating experience into strategic intelligence anyone on the team can access.

Katogen Engine™

Strategic intelligence on demand. Ask a question about deal structure, capital strategy, or market positioning, and get answers informed by 17 acquisitions and $4B in capital raises.

BoardMemos™

Board-quality strategic communications, generated from operating data. Transform raw intelligence into decision-ready briefings.

Katogen Sentinel™

Continuous monitoring of market signals, regulatory changes, and competitive moves across the biopharma landscape. Know before the market does.

Consultants study deals.
Operators close them.

Katogen exists because the biopharma industry deserves advisors who have actually built companies, structured capital raises, integrated acquisitions, and navigated board crises. Not from a slide deck, from the CEO chair. That operating DNA is now encoded into AI, and KatogenOS is the system that makes it scale.